Smith & Nephew gets FDA clearance to expand indications for devices Smith & Nephew announced that it has received FDA clearance to expand the indications within the hip for its innovative HEALICOIL PK Suture Anchor and OSTEORAPTOR Suture Anchor. Indications for the HEALICOIL PK Suture Anchor have been expanded to include abductor repair while those for the OSTEORAPTOR Suture Anchor now include labral reconstruction. Both products and new techniques will be showcased at this week's International Society for Hip Arthroscopy Annual meeting in Boston.
News For SNN From The Last 14 Days
Check below for free stories on SNN the last two weeks.
Smith & Nephew upgraded to Outperform from Market Perform at Bernstein Bernstein upgraded Smith & Nephew due to expectations for a recovery in orthopaedics growth rates in 2014 driven by the launch of the Journey 2 knee and a bottom in BHR hip sales.